Michael Stratton (English Wikipedia)

Anon (2015). "Stratton, Prof. Michael Rudolf". Who's Who (online Oxford University Press ed.). A & C Black. doi:10.1093/ww/9780199540884.013.U36509. (Subscription or UK public library membership required.)
Rahman, N; Arbour, L; Tonin, P; Renshaw, J; Pelletier, J; Baruchel, S; Pritchard-Jones, K; Stratton, M. R.; Narod, S. A. (1996). "Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21". Nature Genetics. 13 (4): 461–3. doi:10.1038/ng0896-461. PMID 8696342. S2CID 19914321.
Rahman, N; Abidi, F; Ford, D; Arbour, L; Rapley, E; Tonin, P; Barton, D; Batcup, G; Berry, J; Cotter, F; Davison, V; Gerrard, M; Gray, E; Grundy, R; Hanafy, M; King, D; Lewis, I; Ridolfi Luethy, A; Madlensky, L; Mann, J; O'Meara, A; Oakhill, T; Skolnick, M; Strong, L; Stratton, M. R. (1998). "Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1". Human Genetics. 103 (5): 547–56. doi:10.1007/pl00008708. PMID 9860296. S2CID 7082835.
International Cancer Genome Consortium; Hudson, T. J.; Anderson, W; Artez, A; Barker, A. D.; Bell, C; Bernabé, R. R.; Bhan, M. K.; Calvo, F; Eerola, I; Gerhard, D. S.; Guttmacher, A; Guyer, M; Hemsley, F. M.; Jennings, J. L.; Kerr, D; Klatt, P; Kolar, P; Kusada, J; Lane, D. P.; Laplace, F; Youyong, L; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, T. S.; Remacle, J; Schafer, A. J.; Shibata, T; et al. (2010). "International network of cancer genome projects". Nature. 464 (7291): 993–8. Bibcode:2010Natur.464..993T. doi:10.1038/nature08987. PMC 2902243. PMID 20393554.
Mattison, J; Kool, J; Uren, A. G.; De Ridder, J; Wessels, L; Jonkers, J; Bignell, G. R.; Butler, A; Rust, A. G.; Brosch, M; Wilson, C. H.; Van Der Weyden, L; Largaespada, D. A.; Stratton, M. R.; Futreal, P. A.; Van Lohuizen, M; Berns, A; Collier, L. S.; Hubbard, T; Adams, D. J. (2010). "Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach". Cancer Research. 70 (3): 883–95. doi:10.1158/0008-5472.CAN-09-1737. PMC 2880710. PMID 20103622.
Futreal, P. A.; Coin, L; Marshall, M; Down, T; Hubbard, T; Wooster, R; Rahman, N; Stratton, M. R. (2004). "A census of human cancer genes". Nature Reviews Cancer. 4 (3): 177–83. doi:10.1038/nrc1299. PMC 2665285. PMID 14993899.
Rapley, E. A.; Crockford, G. P.; Teare, D; Biggs, P; Seal, S; Barfoot, R; Edwards, S; Hamoudi, R; Heimdal, K; Fossâ, S. D.; Tucker, K; Donald, J; Collins, F; Friedlander, M; Hogg, D; Goss, P; Heidenreich, A; Ormiston, W; Daly, P. A.; Forman, D; Oliver, T. D.; Leahy, M; Huddart, R; Cooper, C. S.; Bodmer, J. G.; Easton, D. F.; Stratton, M. R.; Bishop, D. T. (2000). "Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours". Nature Genetics. 24 (2): 197–200. doi:10.1038/72877. PMID 10655070. S2CID 9095109.
Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Höglund, P.; Järvinen, H.; Kristo, P.; Pelin, K.; Ridanpää, M.; Salovaara, R.; Toro, T.; Bodmer, W.; Olschwang, S.; Olsen, A. S.; Stratton, M. R.; de la Chapelle, A.; Aaltonen, L. A. (1998). "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome". Nature. 391 (6663): 184–7. Bibcode:1998Natur.391..184H. doi:10.1038/34432. PMID 9428765. S2CID 4400728.
Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.
Connor, F; Smith, A; Wooster, R; Stratton, M; Dixon, A; Campbell, E; Tait, T. M.; Freeman, T; Ashworth, A (1997). "Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene". Human Molecular Genetics. 6 (2): 291–300. doi:10.1093/hmg/6.2.291. PMID 9063750.
Bignell, G; Micklem, G; Stratton, M. R.; Ashworth, A; Wooster, R (1997). "The BRC repeats are conserved in mammalian BRCA2 proteins". Human Molecular Genetics. 6 (1): 53–8. doi:10.1093/hmg/6.1.53. PMID 9002670.
Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Hutchinson, E. (2001). "Richard Wooster on cancer and the Human Genome Project". The Lancet Oncology. 2 (3): 176–8. doi:10.1016/S1470-2045(00)00261-8. PMID 11902570.
Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Mangion, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G.; Barfoot, R.; Hamoudi, R.; Patel, S.; Rices, C.; Biggs, P.; Hashim, Y.; Smith, A.; Connor, F.; Arason, A.; Gudmundsson, J.; Ficenec, D.; Kelsell, D.; Tonin, P.; Timothy Bishop, D.; Spurr, N. K.; Ponder, B. A. J.; Eeles, R.; Peto, J.; Devilee, P.; Cornelisse, C. (1995). "Identification of the breast cancer susceptibility gene BRCA2". Nature. 378 (6559): 789–792. Bibcode:1995Natur.378..789W. doi:10.1038/378789a0. PMID 8524414. S2CID 4346791.
Meijers-Heijboer, H; Van Den Ouweland, A; Klijn, J; Wasielewski, M; De Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; Van Veghel-Plandsoen, M; Elstrodt, F; Van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, D; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, D. G.; Houlston, R; Murday, V; Narod, S; et al. (2002). "Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations". Nature Genetics. 31 (1): 55–9. doi:10.1038/ng879. PMID 11967536. S2CID 195216803.
Renwick A, Thompson D, Seal S, et al. (August 2006). "ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles". Nat. Genet. 38 (8): 873–5. doi:10.1038/ng1837. PMID 16832357. S2CID 2909283.
Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, D. G.; Eccles, D; Breast Cancer Susceptibility Collaboration (UK); Easton, D. F.; Stratton, M. R. (2007). "PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene". Nature Genetics. 39 (2): 165–7. doi:10.1038/ng1959. PMC 2871593. PMID 17200668.
Burton, P. R.; Clayton, D. G.; Cardon, L. R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D. P.; McCarthy, M. I.; Ouwehand, W. H.; Samani, N. J.; Todd, J. A.; Donnelly, P.; Barrett, J. C.; Burton, P. R.; Davison, D.; Donnelly, P.; Easton, D.; Evans, D.; Leung, H. T.; Marchini, J. L.; Morris, A. P.; Spencer, C. C. A.; Tobin, M. D.; Cardon, L. R.; Clayton, D. G.; Attwood, A. P.; Boorman, J. P.; Cant, B.; Everson, U.; et al. (2007). "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls". Nature. 447 (7145): 661–678. Bibcode:2007Natur.447..661B. doi:10.1038/nature05911. PMC 2719288. PMID 17554300.
Davies, H.; Bignell, G. R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M. J.; Bottomley, W.; Davis, N.; Dicks, E.; Ewing, R.; Floyd, Y.; Gray, K.; Hall, S.; Hawes, R.; Hughes, J.; Kosmidou, V.; Menzies, A.; Mould, C.; Parker, A.; Stevens, C.; Watt, S.; Hooper, S.; Wilson, R.; Jayatilake, H.; Gusterson, B. A.; Cooper, C.; Shipley, J. (2002). "Mutations of the BRAF gene in human cancer" (PDF). Nature. 417 (6892): 949–954. doi:10.1038/nature00766. PMID 12068308. S2CID 3071547.
Stephens, Philip; Hunter, Chris; Bignell, Graham; Edkins, Sarah; Davies, Helen; Teague, Jon; et al. (2004). "Intragenic ERBB2 kinase mutations in tumours". Nature. 431 (7008). Springer Science and Business Media LLC: 525–526. doi:10.1038/431525b. ISSN 0028-0836. PMID 15457249. S2CID 4313058.
Stephens PJ, McBride DJ, Lin ML, et al. (December 2009). "Complex landscapes of somatic rearrangement in human breast cancer genomes". Nature. 462 (7276): 1005–10. Bibcode:2009Natur.462.1005S. doi:10.1038/nature08645. PMC 3398135. PMID 20033038.
Forbes SA, Tang G, Bindal N, et al. (January 2010). "COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer". Nucleic Acids Res. 38 (Database issue): D652–7. doi:10.1093/nar/gkp995. PMC 2808858. PMID 19906727.
Else, Holly (2018). "Sanger whistle-blowers dispute findings that cleared management of bullying". Nature. 563 (7731): 304–305. Bibcode:2018Natur.563..304E. doi:10.1038/d41586-018-07339-4. PMID 30425362. S2CID 53305689.

gla.ac.uk

eprints.gla.ac.uk

Davies, H.; Bignell, G. R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M. J.; Bottomley, W.; Davis, N.; Dicks, E.; Ewing, R.; Floyd, Y.; Gray, K.; Hall, S.; Hawes, R.; Hughes, J.; Kosmidou, V.; Menzies, A.; Mould, C.; Parker, A.; Stevens, C.; Watt, S.; Hooper, S.; Wilson, R.; Jayatilake, H.; Gusterson, B. A.; Cooper, C.; Shipley, J. (2002). "Mutations of the BRAF gene in human cancer" (PDF). Nature. 417 (6892): 949–954. doi:10.1038/nature00766. PMID 12068308. S2CID 3071547.

google.co.uk

scholar.google.co.uk

Michael Stratton's publications in Google Scholar

harvard.edu

ui.adsabs.harvard.edu

International Cancer Genome Consortium; Hudson, T. J.; Anderson, W; Artez, A; Barker, A. D.; Bell, C; Bernabé, R. R.; Bhan, M. K.; Calvo, F; Eerola, I; Gerhard, D. S.; Guttmacher, A; Guyer, M; Hemsley, F. M.; Jennings, J. L.; Kerr, D; Klatt, P; Kolar, P; Kusada, J; Lane, D. P.; Laplace, F; Youyong, L; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, T. S.; Remacle, J; Schafer, A. J.; Shibata, T; et al. (2010). "International network of cancer genome projects". Nature. 464 (7291): 993–8. Bibcode:2010Natur.464..993T. doi:10.1038/nature08987. PMC 2902243. PMID 20393554.
Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Höglund, P.; Järvinen, H.; Kristo, P.; Pelin, K.; Ridanpää, M.; Salovaara, R.; Toro, T.; Bodmer, W.; Olschwang, S.; Olsen, A. S.; Stratton, M. R.; de la Chapelle, A.; Aaltonen, L. A. (1998). "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome". Nature. 391 (6663): 184–7. Bibcode:1998Natur.391..184H. doi:10.1038/34432. PMID 9428765. S2CID 4400728.
Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Mangion, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G.; Barfoot, R.; Hamoudi, R.; Patel, S.; Rices, C.; Biggs, P.; Hashim, Y.; Smith, A.; Connor, F.; Arason, A.; Gudmundsson, J.; Ficenec, D.; Kelsell, D.; Tonin, P.; Timothy Bishop, D.; Spurr, N. K.; Ponder, B. A. J.; Eeles, R.; Peto, J.; Devilee, P.; Cornelisse, C. (1995). "Identification of the breast cancer susceptibility gene BRCA2". Nature. 378 (6559): 789–792. Bibcode:1995Natur.378..789W. doi:10.1038/378789a0. PMID 8524414. S2CID 4346791.
Burton, P. R.; Clayton, D. G.; Cardon, L. R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D. P.; McCarthy, M. I.; Ouwehand, W. H.; Samani, N. J.; Todd, J. A.; Donnelly, P.; Barrett, J. C.; Burton, P. R.; Davison, D.; Donnelly, P.; Easton, D.; Evans, D.; Leung, H. T.; Marchini, J. L.; Morris, A. P.; Spencer, C. C. A.; Tobin, M. D.; Cardon, L. R.; Clayton, D. G.; Attwood, A. P.; Boorman, J. P.; Cant, B.; Everson, U.; et al. (2007). "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls". Nature. 447 (7145): 661–678. Bibcode:2007Natur.447..661B. doi:10.1038/nature05911. PMC 2719288. PMID 17554300.
Stephens PJ, McBride DJ, Lin ML, et al. (December 2009). "Complex landscapes of somatic rearrangement in human breast cancer genomes". Nature. 462 (7276): 1005–10. Bibcode:2009Natur.462.1005S. doi:10.1038/nature08645. PMC 3398135. PMID 20033038.
Else, Holly (2018). "Sanger whistle-blowers dispute findings that cleared management of bullying". Nature. 563 (7731): 304–305. Bibcode:2018Natur.563..304E. doi:10.1038/d41586-018-07339-4. PMID 30425362. S2CID 53305689.

jeantet.ch

Louis-Jeantet Prize

jisc.ac.uk

copac.jisc.ac.uk

Rahman, Nazneen (1999). Localisation and characterisation of the familial tumour gene, FWT1 (PhD thesis). University of London. EThOS uk.bl.ethos.314056.

london.ac.uk

catalogue.libraries.london.ac.uk

Stratton, Michael Rudolf (1990). Role of genetic alterations in the genesis of human soft tissue tumours and medulloblastoma. london.ac.uk (PhD thesis). University of London. OCLC 940324613.

microsoft.com

academic.microsoft.com

Michael Stratton publications indexed by Microsoft Academic

nih.gov

pubmed.ncbi.nlm.nih.gov

Rahman, N; Arbour, L; Tonin, P; Renshaw, J; Pelletier, J; Baruchel, S; Pritchard-Jones, K; Stratton, M. R.; Narod, S. A. (1996). "Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21". Nature Genetics. 13 (4): 461–3. doi:10.1038/ng0896-461. PMID 8696342. S2CID 19914321.
Rahman, N; Abidi, F; Ford, D; Arbour, L; Rapley, E; Tonin, P; Barton, D; Batcup, G; Berry, J; Cotter, F; Davison, V; Gerrard, M; Gray, E; Grundy, R; Hanafy, M; King, D; Lewis, I; Ridolfi Luethy, A; Madlensky, L; Mann, J; O'Meara, A; Oakhill, T; Skolnick, M; Strong, L; Stratton, M. R. (1998). "Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1". Human Genetics. 103 (5): 547–56. doi:10.1007/pl00008708. PMID 9860296. S2CID 7082835.
International Cancer Genome Consortium; Hudson, T. J.; Anderson, W; Artez, A; Barker, A. D.; Bell, C; Bernabé, R. R.; Bhan, M. K.; Calvo, F; Eerola, I; Gerhard, D. S.; Guttmacher, A; Guyer, M; Hemsley, F. M.; Jennings, J. L.; Kerr, D; Klatt, P; Kolar, P; Kusada, J; Lane, D. P.; Laplace, F; Youyong, L; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, T. S.; Remacle, J; Schafer, A. J.; Shibata, T; et al. (2010). "International network of cancer genome projects". Nature. 464 (7291): 993–8. Bibcode:2010Natur.464..993T. doi:10.1038/nature08987. PMC 2902243. PMID 20393554.
Mattison, J; Kool, J; Uren, A. G.; De Ridder, J; Wessels, L; Jonkers, J; Bignell, G. R.; Butler, A; Rust, A. G.; Brosch, M; Wilson, C. H.; Van Der Weyden, L; Largaespada, D. A.; Stratton, M. R.; Futreal, P. A.; Van Lohuizen, M; Berns, A; Collier, L. S.; Hubbard, T; Adams, D. J. (2010). "Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach". Cancer Research. 70 (3): 883–95. doi:10.1158/0008-5472.CAN-09-1737. PMC 2880710. PMID 20103622.
Futreal, P. A.; Coin, L; Marshall, M; Down, T; Hubbard, T; Wooster, R; Rahman, N; Stratton, M. R. (2004). "A census of human cancer genes". Nature Reviews Cancer. 4 (3): 177–83. doi:10.1038/nrc1299. PMC 2665285. PMID 14993899.
Rapley, E. A.; Crockford, G. P.; Teare, D; Biggs, P; Seal, S; Barfoot, R; Edwards, S; Hamoudi, R; Heimdal, K; Fossâ, S. D.; Tucker, K; Donald, J; Collins, F; Friedlander, M; Hogg, D; Goss, P; Heidenreich, A; Ormiston, W; Daly, P. A.; Forman, D; Oliver, T. D.; Leahy, M; Huddart, R; Cooper, C. S.; Bodmer, J. G.; Easton, D. F.; Stratton, M. R.; Bishop, D. T. (2000). "Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours". Nature Genetics. 24 (2): 197–200. doi:10.1038/72877. PMID 10655070. S2CID 9095109.
Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Höglund, P.; Järvinen, H.; Kristo, P.; Pelin, K.; Ridanpää, M.; Salovaara, R.; Toro, T.; Bodmer, W.; Olschwang, S.; Olsen, A. S.; Stratton, M. R.; de la Chapelle, A.; Aaltonen, L. A. (1998). "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome". Nature. 391 (6663): 184–7. Bibcode:1998Natur.391..184H. doi:10.1038/34432. PMID 9428765. S2CID 4400728.
Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.
Connor, F; Smith, A; Wooster, R; Stratton, M; Dixon, A; Campbell, E; Tait, T. M.; Freeman, T; Ashworth, A (1997). "Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene". Human Molecular Genetics. 6 (2): 291–300. doi:10.1093/hmg/6.2.291. PMID 9063750.
Bignell, G; Micklem, G; Stratton, M. R.; Ashworth, A; Wooster, R (1997). "The BRC repeats are conserved in mammalian BRCA2 proteins". Human Molecular Genetics. 6 (1): 53–8. doi:10.1093/hmg/6.1.53. PMID 9002670.
Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Hutchinson, E. (2001). "Richard Wooster on cancer and the Human Genome Project". The Lancet Oncology. 2 (3): 176–8. doi:10.1016/S1470-2045(00)00261-8. PMID 11902570.
Wooster, R.; Neuhausen, S.; Mangion, J.; Quirk, Y.; Ford, D.; Collins, N.; Nguyen, K.; Seal, S.; Tran, T.; Averill, D.; Et, A. (1994). "Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13". Science. 265 (5181): 2088–2090. Bibcode:1994Sci...265.2088W. doi:10.1126/science.8091231. PMID 8091231.
Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Mangion, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G.; Barfoot, R.; Hamoudi, R.; Patel, S.; Rices, C.; Biggs, P.; Hashim, Y.; Smith, A.; Connor, F.; Arason, A.; Gudmundsson, J.; Ficenec, D.; Kelsell, D.; Tonin, P.; Timothy Bishop, D.; Spurr, N. K.; Ponder, B. A. J.; Eeles, R.; Peto, J.; Devilee, P.; Cornelisse, C. (1995). "Identification of the breast cancer susceptibility gene BRCA2". Nature. 378 (6559): 789–792. Bibcode:1995Natur.378..789W. doi:10.1038/378789a0. PMID 8524414. S2CID 4346791.
Meijers-Heijboer, H; Van Den Ouweland, A; Klijn, J; Wasielewski, M; De Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; Van Veghel-Plandsoen, M; Elstrodt, F; Van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, D; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, D. G.; Houlston, R; Murday, V; Narod, S; et al. (2002). "Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations". Nature Genetics. 31 (1): 55–9. doi:10.1038/ng879. PMID 11967536. S2CID 195216803.
Renwick A, Thompson D, Seal S, et al. (August 2006). "ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles". Nat. Genet. 38 (8): 873–5. doi:10.1038/ng1837. PMID 16832357. S2CID 2909283.
Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, D. G.; Eccles, D; Breast Cancer Susceptibility Collaboration (UK); Easton, D. F.; Stratton, M. R. (2007). "PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene". Nature Genetics. 39 (2): 165–7. doi:10.1038/ng1959. PMC 2871593. PMID 17200668.
Burton, P. R.; Clayton, D. G.; Cardon, L. R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D. P.; McCarthy, M. I.; Ouwehand, W. H.; Samani, N. J.; Todd, J. A.; Donnelly, P.; Barrett, J. C.; Burton, P. R.; Davison, D.; Donnelly, P.; Easton, D.; Evans, D.; Leung, H. T.; Marchini, J. L.; Morris, A. P.; Spencer, C. C. A.; Tobin, M. D.; Cardon, L. R.; Clayton, D. G.; Attwood, A. P.; Boorman, J. P.; Cant, B.; Everson, U.; et al. (2007). "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls". Nature. 447 (7145): 661–678. Bibcode:2007Natur.447..661B. doi:10.1038/nature05911. PMC 2719288. PMID 17554300.
Davies, H.; Bignell, G. R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M. J.; Bottomley, W.; Davis, N.; Dicks, E.; Ewing, R.; Floyd, Y.; Gray, K.; Hall, S.; Hawes, R.; Hughes, J.; Kosmidou, V.; Menzies, A.; Mould, C.; Parker, A.; Stevens, C.; Watt, S.; Hooper, S.; Wilson, R.; Jayatilake, H.; Gusterson, B. A.; Cooper, C.; Shipley, J. (2002). "Mutations of the BRAF gene in human cancer" (PDF). Nature. 417 (6892): 949–954. doi:10.1038/nature00766. PMID 12068308. S2CID 3071547.
Stephens, Philip; Hunter, Chris; Bignell, Graham; Edkins, Sarah; Davies, Helen; Teague, Jon; et al. (2004). "Intragenic ERBB2 kinase mutations in tumours". Nature. 431 (7008). Springer Science and Business Media LLC: 525–526. doi:10.1038/431525b. ISSN 0028-0836. PMID 15457249. S2CID 4313058.
Stephens PJ, McBride DJ, Lin ML, et al. (December 2009). "Complex landscapes of somatic rearrangement in human breast cancer genomes". Nature. 462 (7276): 1005–10. Bibcode:2009Natur.462.1005S. doi:10.1038/nature08645. PMC 3398135. PMID 20033038.
Forbes SA, Tang G, Bindal N, et al. (January 2010). "COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer". Nucleic Acids Res. 38 (Database issue): D652–7. doi:10.1093/nar/gkp995. PMC 2808858. PMID 19906727.
Else, Holly (2018). "Sanger whistle-blowers dispute findings that cleared management of bullying". Nature. 563 (7731): 304–305. Bibcode:2018Natur.563..304E. doi:10.1038/d41586-018-07339-4. PMID 30425362. S2CID 53305689.

ncbi.nlm.nih.gov

International Cancer Genome Consortium; Hudson, T. J.; Anderson, W; Artez, A; Barker, A. D.; Bell, C; Bernabé, R. R.; Bhan, M. K.; Calvo, F; Eerola, I; Gerhard, D. S.; Guttmacher, A; Guyer, M; Hemsley, F. M.; Jennings, J. L.; Kerr, D; Klatt, P; Kolar, P; Kusada, J; Lane, D. P.; Laplace, F; Youyong, L; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, T. S.; Remacle, J; Schafer, A. J.; Shibata, T; et al. (2010). "International network of cancer genome projects". Nature. 464 (7291): 993–8. Bibcode:2010Natur.464..993T. doi:10.1038/nature08987. PMC 2902243. PMID 20393554.
Mattison, J; Kool, J; Uren, A. G.; De Ridder, J; Wessels, L; Jonkers, J; Bignell, G. R.; Butler, A; Rust, A. G.; Brosch, M; Wilson, C. H.; Van Der Weyden, L; Largaespada, D. A.; Stratton, M. R.; Futreal, P. A.; Van Lohuizen, M; Berns, A; Collier, L. S.; Hubbard, T; Adams, D. J. (2010). "Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach". Cancer Research. 70 (3): 883–95. doi:10.1158/0008-5472.CAN-09-1737. PMC 2880710. PMID 20103622.
Futreal, P. A.; Coin, L; Marshall, M; Down, T; Hubbard, T; Wooster, R; Rahman, N; Stratton, M. R. (2004). "A census of human cancer genes". Nature Reviews Cancer. 4 (3): 177–83. doi:10.1038/nrc1299. PMC 2665285. PMID 14993899.
Roth, S; Kristo, P; Auranen, A; Shayehgi, M; Seal, S; Collins, N; Barfoot, R; Rahman, N; Klemi, P. J.; Grénman, S; Sarantaus, L; Nevanlinna, H; Butzow, R; Ashworth, A; Stratton, M. R.; Aaltonen, L. A. (1998). "A missense mutation in the BRCA2 gene in three siblings with ovarian cancer". British Journal of Cancer. 77 (8): 1199–202. doi:10.1038/bjc.1998.202. PMC 2150153. PMID 9579822.
Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, D. G.; Eccles, D; Breast Cancer Susceptibility Collaboration (UK); Easton, D. F.; Stratton, M. R. (2007). "PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene". Nature Genetics. 39 (2): 165–7. doi:10.1038/ng1959. PMC 2871593. PMID 17200668.
Burton, P. R.; Clayton, D. G.; Cardon, L. R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D. P.; McCarthy, M. I.; Ouwehand, W. H.; Samani, N. J.; Todd, J. A.; Donnelly, P.; Barrett, J. C.; Burton, P. R.; Davison, D.; Donnelly, P.; Easton, D.; Evans, D.; Leung, H. T.; Marchini, J. L.; Morris, A. P.; Spencer, C. C. A.; Tobin, M. D.; Cardon, L. R.; Clayton, D. G.; Attwood, A. P.; Boorman, J. P.; Cant, B.; Everson, U.; et al. (2007). "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls". Nature. 447 (7145): 661–678. Bibcode:2007Natur.447..661B. doi:10.1038/nature05911. PMC 2719288. PMID 17554300.
Stephens PJ, McBride DJ, Lin ML, et al. (December 2009). "Complex landscapes of somatic rearrangement in human breast cancer genomes". Nature. 462 (7276): 1005–10. Bibcode:2009Natur.462.1005S. doi:10.1038/nature08645. PMC 3398135. PMID 20033038.
Forbes SA, Tang G, Bindal N, et al. (January 2010). "COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer". Nucleic Acids Res. 38 (Database issue): D652–7. doi:10.1093/nar/gkp995. PMC 2808858. PMID 19906727.

rcuk.ac.uk

gtr.rcuk.ac.uk

"UK Government research grants awarded to Michael Stratton". Research Councils UK. Archived from the original on 15 April 2015.

royalmarsden.nhs.uk

"Royal Marsden: Professor Nazneen Rahman". Archived from the original on 2 February 2015.

royalsociety.org

"EC/2008/40: Stratton, Michael Rudolf". London: The Royal Society. Archived from the original on 20 January 2014.
Royal Medal 2024

royalsociety.tv

Patterns of mutation in human cancer genomes – video of a seminar given by Stratton at the Royal Society.

sanger.ac.uk

"Professor Mike Stratton appointed new Director". Wellcome Trust Sanger Institute. Archived from the original on 2 February 2013.
"Mike Stratton". Wellcome Trust Sanger Institute Website. Wellcome Trust Sanger Institute. Retrieved 24 June 2010.
"Result of independent investigation into whistleblowing allegations released". Sanger Institute. 31 October 2018. Retrieved 31 October 2018.
Thomas Kibling (31 October 2018). "Thomas Kibling's Investigatory Report" (PDF). Sanger Institute. Retrieved 31 October 2018.

ftp.sanger.ac.uk

Alexandrov, Ludmil (2014). Signatures of mutational processes in human cancer (PDF). sanger.ac.uk (PhD thesis). University of Cambridge. OCLC 1064595163. EThOS uk.bl.ethos.708130.

scopus.com

Michael Stratton's publications indexed by the Scopus bibliographic database. (subscription required)

semanticscholar.org

api.semanticscholar.org

Rahman, N; Arbour, L; Tonin, P; Renshaw, J; Pelletier, J; Baruchel, S; Pritchard-Jones, K; Stratton, M. R.; Narod, S. A. (1996). "Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21". Nature Genetics. 13 (4): 461–3. doi:10.1038/ng0896-461. PMID 8696342. S2CID 19914321.
Rahman, N; Abidi, F; Ford, D; Arbour, L; Rapley, E; Tonin, P; Barton, D; Batcup, G; Berry, J; Cotter, F; Davison, V; Gerrard, M; Gray, E; Grundy, R; Hanafy, M; King, D; Lewis, I; Ridolfi Luethy, A; Madlensky, L; Mann, J; O'Meara, A; Oakhill, T; Skolnick, M; Strong, L; Stratton, M. R. (1998). "Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1". Human Genetics. 103 (5): 547–56. doi:10.1007/pl00008708. PMID 9860296. S2CID 7082835.
Rapley, E. A.; Crockford, G. P.; Teare, D; Biggs, P; Seal, S; Barfoot, R; Edwards, S; Hamoudi, R; Heimdal, K; Fossâ, S. D.; Tucker, K; Donald, J; Collins, F; Friedlander, M; Hogg, D; Goss, P; Heidenreich, A; Ormiston, W; Daly, P. A.; Forman, D; Oliver, T. D.; Leahy, M; Huddart, R; Cooper, C. S.; Bodmer, J. G.; Easton, D. F.; Stratton, M. R.; Bishop, D. T. (2000). "Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours". Nature Genetics. 24 (2): 197–200. doi:10.1038/72877. PMID 10655070. S2CID 9095109.
Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Höglund, P.; Järvinen, H.; Kristo, P.; Pelin, K.; Ridanpää, M.; Salovaara, R.; Toro, T.; Bodmer, W.; Olschwang, S.; Olsen, A. S.; Stratton, M. R.; de la Chapelle, A.; Aaltonen, L. A. (1998). "A serine/threonine kinase gene defective in Peutz-Jeghers syndrome". Nature. 391 (6663): 184–7. Bibcode:1998Natur.391..184H. doi:10.1038/34432. PMID 9428765. S2CID 4400728.
Lancaster, J. M.; Wooster, R; Mangion, J; Phelan, C. M.; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, R. W.; Berchuck, A; Iglehart, J. D.; Marks, J. R.; Ashworth, A; Stratton, M. R.; Futreal, P. A. (1996). "BRCA2 mutations in primary breast and ovarian cancers". Nature Genetics. 13 (2): 238–40. doi:10.1038/ng0696-238. PMID 8640235. S2CID 26808443.
Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Mangion, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G.; Barfoot, R.; Hamoudi, R.; Patel, S.; Rices, C.; Biggs, P.; Hashim, Y.; Smith, A.; Connor, F.; Arason, A.; Gudmundsson, J.; Ficenec, D.; Kelsell, D.; Tonin, P.; Timothy Bishop, D.; Spurr, N. K.; Ponder, B. A. J.; Eeles, R.; Peto, J.; Devilee, P.; Cornelisse, C. (1995). "Identification of the breast cancer susceptibility gene BRCA2". Nature. 378 (6559): 789–792. Bibcode:1995Natur.378..789W. doi:10.1038/378789a0. PMID 8524414. S2CID 4346791.
Meijers-Heijboer, H; Van Den Ouweland, A; Klijn, J; Wasielewski, M; De Snoo, A; Oldenburg, R; Hollestelle, A; Houben, M; Crepin, E; Van Veghel-Plandsoen, M; Elstrodt, F; Van Duijn, C; Bartels, C; Meijers, C; Schutte, M; McGuffog, L; Thompson, D; Easton, D; Sodha, N; Seal, S; Barfoot, R; Mangion, J; Chang-Claude, J; Eccles, D; Eeles, R; Evans, D. G.; Houlston, R; Murday, V; Narod, S; et al. (2002). "Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations". Nature Genetics. 31 (1): 55–9. doi:10.1038/ng879. PMID 11967536. S2CID 195216803.
Renwick A, Thompson D, Seal S, et al. (August 2006). "ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles". Nat. Genet. 38 (8): 873–5. doi:10.1038/ng1837. PMID 16832357. S2CID 2909283.
Davies, H.; Bignell, G. R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M. J.; Bottomley, W.; Davis, N.; Dicks, E.; Ewing, R.; Floyd, Y.; Gray, K.; Hall, S.; Hawes, R.; Hughes, J.; Kosmidou, V.; Menzies, A.; Mould, C.; Parker, A.; Stevens, C.; Watt, S.; Hooper, S.; Wilson, R.; Jayatilake, H.; Gusterson, B. A.; Cooper, C.; Shipley, J. (2002). "Mutations of the BRAF gene in human cancer" (PDF). Nature. 417 (6892): 949–954. doi:10.1038/nature00766. PMID 12068308. S2CID 3071547.
Stephens, Philip; Hunter, Chris; Bignell, Graham; Edkins, Sarah; Davies, Helen; Teague, Jon; et al. (2004). "Intragenic ERBB2 kinase mutations in tumours". Nature. 431 (7008). Springer Science and Business Media LLC: 525–526. doi:10.1038/431525b. ISSN 0028-0836. PMID 15457249. S2CID 4313058.
Else, Holly (2018). "Sanger whistle-blowers dispute findings that cleared management of bullying". Nature. 563 (7731): 304–305. Bibcode:2018Natur.563..304E. doi:10.1038/d41586-018-07339-4. PMID 30425362. S2CID 53305689.

the-scientist.com

Karen Hopkin (1 June 2009). "On the MAP". The Scientist. Retrieved 24 June 2010.

thegazette.co.uk

"No. 60534". The London Gazette (Supplement). 15 June 2013. p. 2.

theguardian.com

Marsh, Sarah; Devlin, Hannah (29 August 2018). "Bosses at leading UK science institute accused of bullying staff". The Guardian. Retrieved 29 August 2018.

timesonline.co.uk

Mark Henderson (24 December 2009). "Breast cancer is not a single disease, scientists discover". The Times. Archived from the original on 1 June 2010. Retrieved 24 June 2010.

ukwhoswho.com

Anon (2015). "Stratton, Prof. Michael Rudolf". Who's Who (online Oxford University Press ed.). A & C Black. doi:10.1093/ww/9780199540884.013.U36509. (Subscription or UK public library membership required.)

web.archive.org

"EMBO welcomes 66 leading life scientists as members". biochemist.org. Archived from the original on 17 August 2014.
"Royal Marsden: Professor Nazneen Rahman". Archived from the original on 2 February 2015.
"Feature: Professor Mike Stratton – how I got into cancer genetics 'Wellcome News' issue 66". 2011. Archived from the original on 20 March 2012.
"Professor Mike Stratton appointed new Director". Wellcome Trust Sanger Institute. Archived from the original on 2 February 2013.
Mark Henderson (24 December 2009). "Breast cancer is not a single disease, scientists discover". The Times. Archived from the original on 1 June 2010. Retrieved 24 June 2010.
"UK Government research grants awarded to Michael Stratton". Research Councils UK. Archived from the original on 15 April 2015.

webcitation.org

"EC/2008/40: Stratton, Michael Rudolf". London: The Royal Society. Archived from the original on 20 January 2014.

wellcome.ac.uk

"Feature: Professor Mike Stratton – how I got into cancer genetics 'Wellcome News' issue 66". 2011. Archived from the original on 20 March 2012.
Chrissie Giles (24 June 2010). "Great expectations: human genome research". Wellcome News. Wellcome Trust. Retrieved 24 June 2010.

worldcat.org

search.worldcat.org

Alexandrov, Ludmil (2014). Signatures of mutational processes in human cancer (PDF). sanger.ac.uk (PhD thesis). University of Cambridge. OCLC 1064595163. EThOS uk.bl.ethos.708130.
Stratton, Michael Rudolf (1990). Role of genetic alterations in the genesis of human soft tissue tumours and medulloblastoma. london.ac.uk (PhD thesis). University of London. OCLC 940324613.
Stephens, Philip; Hunter, Chris; Bignell, Graham; Edkins, Sarah; Davies, Helen; Teague, Jon; et al. (2004). "Intragenic ERBB2 kinase mutations in tumours". Nature. 431 (7008). Springer Science and Business Media LLC: 525–526. doi:10.1038/431525b. ISSN 0028-0836. PMID 15457249. S2CID 4313058.